Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas

被引：15
|
作者：
Tang, Vivian [1 ]
Lu, Rufei [1 ]
Mirchia, Kanish [1 ]
Van Ziffle, Jessica [1 ,2 ]
Devine, Patrick [1 ,2 ]
Lee, Julieann [1 ]
Phillips, Joanna J. J. [1 ,3 ]
Perry, Arie [1 ,3 ]
Raleigh, David R. R. [3 ,4 ]
Lucas, Calixto-Hope G. [1 ,5 ]
Solomon, David A. A. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,Hlth Sci West 451, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Clin Canc Genom Lab, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94143 USA
[5] Johns Hopkins Univ, Sch Med, Dept Pathol, 1800 Orleans St,Sheikh Zayed Tower Room 2101, Baltimore, MD 21287 USA
来源：
ACTA NEUROPATHOLOGICA | 2023年 / 145卷 / 04期
关键词：
D O I：
10.1007/s00401-023-02544-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：497 / 500
页数：4
相关论文
共 50 条
  • [41] CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
    Kettunen, Eeva
    Savukoski, Sauli
    Salmenkivi, Kaisa
    Bohling, Tom
    Vanhala, Esa
    Kuosma, Eeva
    Anttila, Sisko
    Wolff, Henrik
    BMC CANCER, 2019, 19 (1)
  • [42] CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure
    Eeva Kettunen
    Sauli Savukoski
    Kaisa Salmenkivi
    Tom Böhling
    Esa Vanhala
    Eeva Kuosma
    Sisko Anttila
    Henrik Wolff
    BMC Cancer, 19
  • [43] FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS
    CAIRNS, P
    POLASCIK, TJ
    EBY, Y
    TOKINO, K
    CALIFANO, J
    MERLO, A
    MAO, L
    HERATH, J
    JENKINS, R
    WESTRA, W
    RUTTER, JL
    BUCKLER, A
    GABRIELSON, E
    TOCKMAN, M
    CHO, KR
    HEDRICK, L
    BOVA, GS
    ISAACS, W
    KOCH, W
    SCHWAB, D
    SIDRANSKY, D
    NATURE GENETICS, 1995, 11 (02) : 210 - 212
  • [44] Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma
    Takita, J
    Hayashi, Y
    Kohno, T
    Yamaguchi, N
    Hanada, R
    Yamamoto, K
    Yokota, J
    CANCER RESEARCH, 1997, 57 (05) : 907 - 912
  • [45] EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index
    Purkait, Suvendu
    Sharma, Vikas
    Jha, Prerana
    Sharma, Mehar Chand
    Suri, Vaishali
    Suri, Ashish
    Sharma, B. S.
    Sarkar, Chitra
    NEUROPATHOLOGY, 2015, 35 (05) : 421 - 431
  • [46] Loss of p16INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas
    Aesif, Scott W.
    Aubry, Marie Christine
    Yi, Eunhee S.
    Kloft-Nelson, Sara M.
    Jenkins, Sarah M.
    Spears, Grant M.
    Greipp, Patricia T.
    Sukov, William R.
    Roden, Anja C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (05) : 860 - 871
  • [47] Loss of p16 (CDKN2A) Expression Is Rare in Dedifferentiated Liposarcoma and Does Not Promote Tumor Progression
    Kang, Y.
    Horvai, A. E.
    MODERN PATHOLOGY, 2014, 27 : 19A - 19A
  • [48] TO ANALYZE FREQUENCY OF CDKN2A DELETION IN EPENDYMOMAS AND COORELATION WITH p16 PROTEIN EXPRESSION, CLINICAL AND HISTOPATHOLOGICAL PARAMETERS
    Chharchhodawala, Taher
    Sable, Mukund
    Sharma, Mehar C.
    Sarkar, Chitra
    Suri, Vaishali
    Singh, Manmohan
    NEURO-ONCOLOGY, 2013, 15 : 161 - 162
  • [49] CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations
    Nielsen, GP
    Burns, KL
    Rosenberg, AE
    Louis, DN
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01): : 159 - 163
  • [50] CDKN2A and MTAP Deletions in Peritoneal Mesotheliomas: Correlation with Loss of p16 Protein Expression and Survival
    Krasinskas, A. M.
    Bartlett, D.
    Cieply, K.
    Dacic, S.
    MODERN PATHOLOGY, 2009, 22 : 136A - 136A
12345